同病症和临床试验招生之间的关联对于子宫癌患者
Ann Oluloro1, Mindy Pike, Tiffany Luu
1Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington.
Obstetrics and gynecology
|December 4, 2025
概括
子宫癌患者的并发症因种族而异,不成比例地影响黑人,影响临床试验资格. 了解这些差异对于公平的试验招聘至关重要.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 健康差异 在健康上的差异
背景情况:
- 子宫癌患者呈现出不同的并发症概况.
- 种族和种族影响并发症的流行率和严重程度.
- 临床试验的资格标准可能会受到伴随性疾病的影响.
研究的目的:
- 通过种族和种族来描述子宫癌患者的并发病概况.
- 量化基于并发症的资格标准对子宫癌临床试验积累的影响.
主要方法:
- 利用Vizient临床数据库 (2002-2021) 对384,093名子宫癌患者进行横截面研究.
- 使用查尔森,埃利克沙瑟和国家癌症研究所指数评估并发症.
- 根据修改的并发症标准计算了理论的资格不合格率,并在种族群体之间进行了比较.
主要成果:
- 与其他种族群体相比,非西班牙裔黑人个人表现出更高的并发症得分和患病率 (例如,功能衰竭,糖尿病,高血压).
- 非西班牙裔黑人患者因并发症而被排除在试验之外的几率是非西班牙裔白人患者的两倍 (aOR 2.06).
- 伴随性疾病的患病率和指数得分因种族而异,影响了基线试验的资格.
结论:
- 在子宫癌患者中共患病率的种族差异影响了临床试验的资格.
- 量化并发症分布对于预测和减轻少数群体试验积累障碍至关重要.
- 这些数据可以为公平的试验设计和有针对性的招聘策略提供信息,以改善癌症研究的多样性.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
628
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.6K
相关概念视频
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:12Hazard Ratio
549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
549
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:21Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
135
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
135